Atlas Trials

Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients with Relapsed Multiple Myeloma

Clinical trial NCT03399539 · COMPLETED

Trial details

NCT number
NCT03399539
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Plasma Cell MyelomaT(11;14)
Start date
2018-05-02
Primary completion
2021-12-20
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.